{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:16:52Z","timestamp":1792189012322,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Cannabis sativa<\/jats:italic>\n                    (\n                    <jats:italic>C. sativa<\/jats:italic>\n                    ) is commonly chemically classified based on its \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -tetrahydrocannabinol (THC) and cannabidiol (CBD) content ratios. However, the plant contains nearly 150 additional cannabinoids, referred to as minor cannabinoids. Minor cannabinoids are gaining interest for improved plant and product characterization, e.g., for medical use, and bioanalytical questions in the medico-legal field. This study describes the development and validation of an analytical method for the elucidation of minor cannabinoid fingerprints, employing liquid chromatography coupled to high-resolution mass spectrometry. The method was used to characterize inflorescences from 18 different varieties of\n                    <jats:italic>C. sativa<\/jats:italic>\n                    , which were cultivated under the same standardized conditions. Complementing the targeted detection of 15 cannabinoids, untargeted metabolomics employing in silico assisted data analysis was used to detect additional plant ingredients with focus on cannabinoids. Principal component analysis (PCA) was used to evaluate differences between varieties. The overall purpose of this study was to examine the ability of targeted and non-targeted metabolomics using the mentioned techniques to distinguish cannabis varieties from each other by their minor cannabinoid fingerprint. Quantitative determination of targeted cannabinoids already gave valuable information on cannabinoid fingerprints as well as inter- and intra-variety variability of cannabinoid contents. The untargeted workflow led to the detection of 19 additional compounds. PCA of the targeted and untargeted datasets revealed further subgroups extending commonly applied phenotype classification systems of cannabis. This study presents an analytical method for the comprehensive characterization of\n                    <jats:italic>C. sativa<\/jats:italic>\n                    varieties.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00216-022-04026-2","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:09:31Z","timestamp":1649142571000},"page":"3847-3862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Beyond \u03949-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis"],"prefix":"10.1007","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-398X","authenticated-orcid":false,"given":"Manuela Carla","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-1901","authenticated-orcid":false,"given":"Priska","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-0422","authenticated-orcid":false,"given":"Eva","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-9065","authenticated-orcid":false,"given":"Katja","family":"Mercer-Chalmers-Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"4026_CR1","first-page":"1","volume-title":"Phytocannabinoids: unraveling the complex chemistry and pharmacology of Cannabis sativa","author":"MA ElSohly","year":"2017","unstructured":"ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. In: Kinghorn AD, Falk H, Gibbons S, Ji K, editors. Phytocannabinoids: unraveling the complex chemistry and pharmacology of Cannabis sativa. Cham: Springer International Publishing; 2017. p. 1\u201336."},{"issue":"10","key":"4026_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.tplants.2020.05.005","volume":"25","author":"T G\u00fclck","year":"2020","unstructured":"G\u00fclck T, M\u00f8ller BL. Phytocannabinoids: origins and biosynthesis. Trends Plant Sci. 2020;25(10):985\u20131004. https:\/\/doi.org\/10.1016\/j.tplants.2020.05.005.","journal-title":"Trends Plant Sci"},{"key":"4026_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","volume":"104","author":"H Carliner","year":"2017","unstructured":"Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the U.S.: a review. Prev Med. 2017;104:13\u201323. https:\/\/doi.org\/10.1016\/j.ypmed.2017.07.008.","journal-title":"Prev Med"},{"key":"4026_CR4","doi-asserted-by":"publisher","first-page":"102556","DOI":"10.1016\/j.drugpo.2019.09.004","volume":"91","author":"M Shanahan","year":"2021","unstructured":"Shanahan M, Cyrenne P. Cannabis policies in Canada: how will we know which is best? Int J Drug Policy. 2021;91:102556. https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.004.","journal-title":"Int J Drug Policy"},{"key":"4026_CR5","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/j.lanepe.2021.100227","volume":"10","author":"J Manthey","year":"2021","unstructured":"Manthey J, Freeman TP, Kilian C, L\u00f3pez-Pelayo H, Rehm J. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur. 2021;10:100227. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100227.","journal-title":"Lancet Reg Health Eur"},{"key":"4026_CR6","doi-asserted-by":"publisher","first-page":"339020","DOI":"10.1016\/j.aca.2021.339020","volume":"1184","author":"PG V\u00e1squez-Ocm\u00edn","year":"2021","unstructured":"V\u00e1squez-Ocm\u00edn PG, Marti G, Bonhomme M, Mathis F, Fournier S, Bertani S, et al. Cannabinoids vs. whole metabolome: relevance of cannabinomics in analyzing Cannabis varieties. Anal Chim Acta. 2021;1184:339020. https:\/\/doi.org\/10.1016\/j.aca.2021.339020.","journal-title":"Anal Chim Acta"},{"issue":"18","key":"4026_CR7","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.3390\/molecules25184042","volume":"25","author":"KS Ladha","year":"2020","unstructured":"Ladha KS, Ajrawat P, Yang Y, Clarke H. Understanding the medical chemistry of the cannabis plant is critical to guiding real world clinical evidence. Molecules. 2020;25(18):4042. https:\/\/doi.org\/10.3390\/molecules25184042.","journal-title":"Molecules"},{"key":"4026_CR8","unstructured":"United Nations. UN commission reclassifies cannabis, yet still considered harmful. https:\/\/news.un.org\/en\/story\/2020\/12\/1079132. Accessed 5 Jan\u00a02022."},{"key":"4026_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/525S2a","volume":"525","author":"J Gould","year":"2015","unstructured":"Gould J. The cannabis crop. Nature. 2015;525:S2. https:\/\/doi.org\/10.1038\/525S2a.","journal-title":"Nature"},{"issue":"3","key":"4026_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","volume":"38","author":"EB Russo","year":"2017","unstructured":"Russo EB. Cannabidiol claims and misconceptions. Trends Pharmacol Sci. 2017;38(3):198\u2013201. https:\/\/doi.org\/10.1016\/j.tips.2016.12.004.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"4026_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30(10):515\u201327. https:\/\/doi.org\/10.1016\/j.tips.2009.07.006.","journal-title":"Trends Pharmacol Sci"},{"key":"4026_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","volume":"175","author":"S Pisanti","year":"2017","unstructured":"Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, et al. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Ther. 2017;175:133\u201350. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.041.","journal-title":"Pharmacol Ther"},{"key":"4026_CR13","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","volume":"9","author":"JA Crippa","year":"2018","unstructured":"Crippa JA, Guimar\u00e3es FS, Campos AC, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Front Immunol. 2018;9:2009. https:\/\/doi.org\/10.3389\/fimmu.2018.02009.","journal-title":"Front Immunol"},{"key":"4026_CR14","doi-asserted-by":"publisher","first-page":"l1141-l","DOI":"10.1136\/bmj.l1141","volume":"365","author":"TP Freeman","year":"2019","unstructured":"Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis based products and cannabinoids. BMJ. 2019;365:l1141-l. https:\/\/doi.org\/10.1136\/bmj.l1141.","journal-title":"BMJ"},{"issue":"12","key":"4026_CR15","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanu\u0161","year":"2016","unstructured":"Hanu\u0161 LO, Meyer SM, Mu\u00f1oz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357\u201392. https:\/\/doi.org\/10.1039\/C6NP00074F.","journal-title":"Nat Prod Rep"},{"key":"4026_CR16","first-page":"1","volume-title":"Cannabis sativa L - botany and biotechnology","author":"E Small","year":"2017","unstructured":"Small E. Classification of Cannabis sativa L. in relation to agricultural, biotechnological, medical and recreational utilization. In: Chandra S, Lata H, ElSohly MA, editors. Cannabis sativa L - botany and biotechnology. Cham: Springer International Publishing; 2017. p. 1\u201362."},{"issue":"5421","key":"4026_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/245147a0","volume":"245","author":"E Small","year":"1973","unstructured":"Small E, Beckstead HD. Cannabinoid phenotypes in Cannabis sativa. Nature. 1973;245(5421):147\u20138. https:\/\/doi.org\/10.1038\/245147a0.","journal-title":"Nature"},{"issue":"7\u20138","key":"4026_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/dta.407","volume":"4","author":"A Hazekamp","year":"2012","unstructured":"Hazekamp A, Fischedick JT. Cannabis - from cultivar to chemovar. Drug Test Anal. 2012;4(7\u20138):660\u20137. https:\/\/doi.org\/10.1002\/dta.407.","journal-title":"Drug Test Anal"},{"issue":"1","key":"4026_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/can.2016.0040","volume":"2","author":"JT Fischedick","year":"2017","unstructured":"Fischedick JT. Identification of terpenoid chemotypes among high (-)-trans-\u0394(9)- tetrahydrocannabinol-producing Cannabis sativa L. cultivars. Cannabis Cannabinoid Res. 2017;2(1):34\u201347. https:\/\/doi.org\/10.1089\/can.2016.0040.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"03","key":"4026_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-2006-962705","volume":"53","author":"G Fournier","year":"1987","unstructured":"Fournier G, Richez-Dumanois C, Duvezin J, Mathieu JP, Paris M. Identification of a new chemotype in Cannabis sativa: cannabigerol - dominant plants, biogenetic and agronomic prospects. Planta Med. 1987;53(03):277\u201380. https:\/\/doi.org\/10.1055\/s-2006-962705.","journal-title":"Planta Med"},{"key":"4026_CR21","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2021. Booklet 3 - Drug market trends: Opioids, Cannabis. https:\/\/www.unodc.org\/res\/wdr2021\/field\/WDR21_Booklet_3.pdf. Accessed 3 Jan\u00a0\u00a02022."},{"issue":"7","key":"4026_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/head.13345","volume":"58","author":"EP Baron","year":"2018","unstructured":"Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science. Headache. 2018;58(7):1139\u201386. https:\/\/doi.org\/10.1111\/head.13345.","journal-title":"Headache"},{"key":"4026_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpls.2016.00019","volume":"7","author":"CM Andre","year":"2016","unstructured":"Andre CM, Hausman J-F, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. https:\/\/doi.org\/10.3389\/fpls.2016.00019.","journal-title":"Front Plant Sci"},{"issue":"1","key":"4026_CR24","doi-asserted-by":"publisher","first-page":"14280","DOI":"10.1038\/s41598-018-32651-4","volume":"8","author":"P Berman","year":"2018","unstructured":"Berman P, Futoran K, Lewitus GM, Mukha D, Benami M, Shlomi T, et al. A new ESI-LC\/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Sci Rep. 2018;8(1):14280. https:\/\/doi.org\/10.1038\/s41598-018-32651-4.","journal-title":"Sci Rep"},{"key":"4026_CR25","doi-asserted-by":"publisher","first-page":"121336","DOI":"10.1016\/j.talanta.2020.121336","volume":"219","author":"P Berman","year":"2020","unstructured":"Berman P, Sulimani L, Gelfand A, Amsalem K, Lewitus GM, Meiri D. Cannabinoidomics \u2013 an analytical approach to understand the effect of medical cannabis treatment on the endocannabinoid metabolome. Talanta. 2020;219:121336. https:\/\/doi.org\/10.1016\/j.talanta.2020.121336.","journal-title":"Talanta"},{"issue":"7","key":"4026_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344\u201364. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01238.x.","journal-title":"Br J Pharmacol"},{"key":"4026_CR27","doi-asserted-by":"publisher","first-page":"122313","DOI":"10.1016\/j.talanta.2021.122313","volume":"230","author":"A Cerrato","year":"2021","unstructured":"Cerrato A, Citti C, Cannazza G, Capriotti AL, Cavaliere C, Grassi G, et al. Phytocannabinomics: untargeted metabolomics as a tool for cannabis chemovar differentiation. Talanta. 2021;230:122313. https:\/\/doi.org\/10.1016\/j.talanta.2021.122313.","journal-title":"Talanta"},{"key":"4026_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.indcrop.2018.01.060","volume":"113","author":"D Namdar","year":"2018","unstructured":"Namdar D, Mazuz M, Ion A, Koltai H. Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods. Ind Crops Prod. 2018;113:376\u201382. https:\/\/doi.org\/10.1016\/j.indcrop.2018.01.060.","journal-title":"Ind Crops Prod"},{"key":"4026_CR29","doi-asserted-by":"publisher","unstructured":"Aliferis KA, Bernard-Perron D. Cannabinomics: application of metabolomics in Cannabis (Cannabis sativa L.) research and development. Front Plant Sci. 2020;11(554). https:\/\/doi.org\/10.3389\/fpls.2020.00554.","DOI":"10.3389\/fpls.2020.00554"},{"key":"4026_CR30","doi-asserted-by":"publisher","first-page":"462492","DOI":"10.1016\/j.chroma.2021.462492","volume":"1655","author":"AL Capriotti","year":"2021","unstructured":"Capriotti AL, Cannazza G, Catani M, Cavaliere C, Cavazzini A, Cerrato A, et al. Recent applications of mass spectrometry for the characterization of cannabis and hemp phytocannabinoids: from targeted to untargeted analysis. J Chromatogr A. 2021;1655:462492. https:\/\/doi.org\/10.1016\/j.chroma.2021.462492.","journal-title":"J Chromatogr A"},{"key":"4026_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpba.2017.11.073","volume":"150","author":"L Calvi","year":"2018","unstructured":"Calvi L, Pentimalli D, Panseri S, Giupponi L, Gelmini F, Beretta G, et al. Comprehensive quality evaluation of medical Cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC\u2013MS and LC-HRMS (q-exactive orbitrap\u00ae) approach. J Pharm Biomed Anal. 2018;150:208\u201319. https:\/\/doi.org\/10.1016\/j.jpba.2017.11.073.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"4026_CR32","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/clinchem\/hvaa113","volume":"66","author":"EL Karschner","year":"2020","unstructured":"Karschner EL, Swortwood-Gates MJ, Huestis MA. Identifying and quantifying cannabinoids in biological matrices in the medical and legal cannabis era. Clin Chem. 2020;66(7):888\u2013914. https:\/\/doi.org\/10.1093\/clinchem\/hvaa113.","journal-title":"Clin Chem"},{"issue":"5","key":"4026_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/metabo11050316","volume":"11","author":"A Scheunemann","year":"2021","unstructured":"Scheunemann A, Elsner K, Germerott T, Groppa S, Hess C, Miederer I, et al. Identification of potential distinguishing markers for the use of cannabis-based medicines or street cannabis in serum samples. Metabolites. 2021;11(5):316. https:\/\/doi.org\/10.3390\/metabo11050316.","journal-title":"Metabolites"},{"key":"4026_CR34","doi-asserted-by":"publisher","first-page":"110773","DOI":"10.1016\/j.forsciint.2021.110773","volume":"322","author":"A Scheunemann","year":"2021","unstructured":"Scheunemann A, Elsner K, Germerott T, Hess C, Z\u00f6rntlein S, R\u00f6hrich J. Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines \u2013 identification of potential distinguishing markers. Forensic Sci Int. 2021;322:110773. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110773.","journal-title":"Forensic Sci Int"},{"issue":"10","key":"4026_CR35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/dta.2682","volume":"11","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Madea B, Hess C. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use? Drug Test Anal. 2019;11(10):1498\u2013506. https:\/\/doi.org\/10.1002\/dta.2682.","journal-title":"Drug Test Anal"},{"issue":"1","key":"4026_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.07.021","volume":"106","author":"FR Levin","year":"2010","unstructured":"Levin FR, Mariani JJ, Brooks DJ, Xie S, Murray KA. \u03949-Tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend. 2010;106(1):65\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.07.021.","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"4026_CR37","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.phytochem.2010.10.001","volume":"71","author":"JT Fischedick","year":"2010","unstructured":"Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry. 2010;71(17):2058\u201373. https:\/\/doi.org\/10.1016\/j.phytochem.2010.10.001.","journal-title":"Phytochemistry"},{"key":"4026_CR38","doi-asserted-by":"publisher","unstructured":"Elzinga S, Fischedick J, Podkolinski R, Raber J. Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat Prod Chem Res. 2015;3(4). https:\/\/doi.org\/10.4172\/2329-6836.1000181.","DOI":"10.4172\/2329-6836.1000181"},{"issue":"1","key":"4026_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2016.0017","volume":"1","author":"A Hazekamp","year":"2016","unstructured":"Hazekamp A, Tejkalov\u00e1 K, Papadimitriou S. Cannabis: from cultivar to chemovar II\u2014a metabolomics approach to cannabis classification. Cannabis Cannabinoid Res. 2016;1(1):202\u201315. https:\/\/doi.org\/10.1089\/can.2016.0017.","journal-title":"Cannabis Cannabinoid Res"},{"key":"4026_CR40","doi-asserted-by":"publisher","first-page":"110228","DOI":"10.1016\/j.forsciint.2020.110228","volume":"310","author":"A Slosse","year":"2020","unstructured":"Slosse A, Van Durme F, Samyn N, Mangelings D, Vander HY. Evaluation of data preprocessings for the comparison of GC\u2013MS chemical profiles of seized cannabis samples. Forensic Sci Int. 2020;310:110228. https:\/\/doi.org\/10.1016\/j.forsciint.2020.110228.","journal-title":"Forensic Sci Int"},{"key":"4026_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-47656-8_7","volume-title":"Metabolomics: from fundamentals to clinical applications","author":"RC Pinto","year":"2017","unstructured":"Pinto RC. Chemometrics methods and strategies in metabolomics. In: Sussulini A, editor. Metabolomics: from fundamentals to clinical applications. Cham: Springer International Publishing; 2017. p. 163\u201390."},{"issue":"2","key":"4026_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/pca.753","volume":"15","author":"TJ Raharjo","year":"2004","unstructured":"Raharjo TJ, Verpoorte R. Methods for the analysis of cannabinoids in biological materials: a review. Phytochem Anal. 2004;15(2):79\u201394. https:\/\/doi.org\/10.1002\/pca.753.","journal-title":"Phytochem Anal"},{"issue":"15","key":"4026_CR43","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1080\/10826070500187558","volume":"28","author":"A Hazekamp","year":"2005","unstructured":"Hazekamp A, Peltenburg A, Verpoorte R, Giroud C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. J Liq Chromatogr Relat Technol. 2005;28(15):2361\u201382. https:\/\/doi.org\/10.1080\/10826070500187558.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"5","key":"4026_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/mas.21551","volume":"37","author":"T De Vijlder","year":"2018","unstructured":"De Vijlder T, Valkenborg D, Lemi\u00e8re F, Romijn EP, Laukens K, Cuyckens F. A tutorial in small molecule identification via electrospray ionization-mass spectrometry: the practical art of structural elucidation. Mass Spectrom Rev. 2018;37(5):607\u201329. https:\/\/doi.org\/10.1002\/mas.21551.","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"4026_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: An R package for multivariate analysis. J Stat Softw. 2008;25(1):1\u201318. https:\/\/doi.org\/10.18637\/jss.v025.i01.","journal-title":"J Stat Softw"},{"key":"4026_CR46","doi-asserted-by":"publisher","unstructured":"Piccolella S, Crescente G, Formato M, Pacifico S. A cup of hemp coffee by Moka Pot from Southern Italy: an UHPLC-HRMS investigation. Foods. 2020;9(8). https:\/\/doi.org\/10.3390\/foods9081123.","DOI":"10.3390\/foods9081123"},{"key":"4026_CR47","doi-asserted-by":"publisher","first-page":"121310","DOI":"10.1016\/j.talanta.2020.121310","volume":"219","author":"CM Montone","year":"2020","unstructured":"Montone CM, Cerrato A, Botta B, Cannazza G, Capriotti AL, Cavaliere C, et al. Improved identification of phytocannabinoids using a dedicated structure-based workflow. Talanta. 2020;219:121310. https:\/\/doi.org\/10.1016\/j.talanta.2020.121310.","journal-title":"Talanta"},{"issue":"27","key":"4026_CR48","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1007\/s00216-020-02862-8","volume":"412","author":"G McRae","year":"2020","unstructured":"McRae G, Melanson JE. Quantitative determination and validation of 17 cannabinoids in cannabis and hemp using liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2020;412(27):7381\u201393. https:\/\/doi.org\/10.1007\/s00216-020-02862-8.","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"4026_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.004.","journal-title":"Biol Psychiatry"},{"key":"4026_CR50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","volume":"107","author":"AM Freeman","year":"2019","unstructured":"Freeman AM, Petrilli K, Lees R, Hindocha C, Mokrysz C, Curran HV, et al. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neurosci Biobehav Rev. 2019;107:696\u2013712. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.036.","journal-title":"Neurosci Biobehav Rev"},{"key":"4026_CR51","doi-asserted-by":"publisher","first-page":"112752","DOI":"10.1016\/j.jpba.2019.06.049","volume":"175","author":"C Citti","year":"2019","unstructured":"Citti C, Linciano P, Forni F, Vandelli MA, Gigli G, Lagan\u00e0 A, et al. Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog. J Pharm Biomed Anal. 2019;175:112752. https:\/\/doi.org\/10.1016\/j.jpba.2019.06.049.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4026_CR52","doi-asserted-by":"publisher","first-page":"22019","DOI":"10.1038\/s41598-020-79042-2","volume":"10","author":"P Linciano","year":"2020","unstructured":"Linciano P, Citti C, Russo F, Tolomeo F, Lagan\u00e0 A, Capriotti AL, et al. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol. Sci Rep. 2020;10(1):22019. https:\/\/doi.org\/10.1038\/s41598-020-79042-2.","journal-title":"Sci Rep"},{"issue":"1","key":"4026_CR53","doi-asserted-by":"publisher","first-page":"20335","DOI":"10.1038\/s41598-019-56785-1","volume":"9","author":"C Citti","year":"2019","unstructured":"Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than \u03949-tetrahydrocannabinol: \u03949-tetrahydrocannabiphorol. Sci Rep. 2019;9(1):20335. https:\/\/doi.org\/10.1038\/s41598-019-56785-1.","journal-title":"Sci Rep."},{"issue":"2","key":"4026_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/acs.jnatprod.0c01034","volume":"84","author":"J Bueno","year":"2021","unstructured":"Bueno J, Greenbaum EA. (\u2212)-trans-\u03949-Tetrahydrocannabiphorol content of Cannabis sativa inflorescence from various chemotypes. J Nat Prod. 2021;84(2):531\u20136. https:\/\/doi.org\/10.1021\/acs.jnatprod.0c01034.","journal-title":"J Nat Prod"},{"key":"4026_CR55","doi-asserted-by":"publisher","unstructured":"Elzinga S, Fischedick J, Podkolinski R, Raber J. Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat Prod Chem Res. 2015;3. https:\/\/doi.org\/10.4172\/2329-6836.1000181.","DOI":"10.4172\/2329-6836.1000181"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-022-04026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-022-04026-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-022-04026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T07:04:36Z","timestamp":1651475076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-022-04026-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1007\/s00216-022-04026-2","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}